SCHEMBL101663

SCHEMBL101663

O=C(Cl)N1CCSC1=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL823726 0.78 — —
SCHEMBL11260067 0.76 — —
SCHEMBL229110 0.74 KMT2A (0.50) —
SCHEMBL10038918 0.74 KMT2A (0.49) —
SCHEMBL14193571 0.71 MAPT (0.47) —
SCHEMBL10047902 0.71 MAPT (0.48) —
SCHEMBL19543209 0.67 MAPT (0.45) —
SCHEMBL12687063 0.66 KMT2A (0.42) —
SCHEMBL6805601 0.66 MAPT (0.42) —
SCHEMBL11253108 0.64 INMT (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343971-B2 Pharmacologically-active vanilloid carbamates RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2013-01-01 — — US claimed
US-20120059007-A1 Pharmacologically-active vanilloid carbamates RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-03-08 — — US claimed
US-11731991-B2 Augmenting moieties for anti-inflammatory compounds LEHIGH UNIVERSITY (US) 2023-08-22 — — US disclosed
US-11731991-B2 Augmenting moieties for anti-inflammatory compounds LEHIGH UNIVERSITY (US) 2023-08-22 — — US disclosed
US-20200369688-A1 Augmenting Moieties for Anti-Inflammatory Compounds RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2020-11-26 — — US disclosed
US-20170044096-A1 Augmenting Moieties for Anti-Inflammatory Compounds LEHIGH UNIVERSITY 2017-02-16 — — US disclosed
US-20170044096-A1 Augmenting Moieties for Anti-Inflammatory Compounds LEHIGH UNIVERSITY 2017-02-16 — — US disclosed
US-9512068-B2 Augmenting moieties for anti-inflammatory compounds RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-12-06 — — US disclosed
US-20160031804-A1 Augmenting Moieties for Anti-Inflammatory Compounds LEHIGH UNIVERSITY 2016-02-04 — — US disclosed
US-8343971-B2 Pharmacologically-active vanilloid carbamates RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2013-01-01 — — US disclosed
US-8343971-B2 Pharmacologically-active vanilloid carbamates RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2013-01-01 — — US disclosed
US-20120059007-A1 Pharmacologically-active vanilloid carbamates RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-03-08 — — US disclosed
US-20120059007-A1 Pharmacologically-active vanilloid carbamates RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-03-08 — — US disclosed
US-4643991-A TREATMENT OF EMPHYSEMA THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 1987-02-17 — — US disclosed
Send feedback